Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting December 14th, 2022.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Gilead Sciences
Symbol: GILD
Recent GILD Stock Price: $88.54
Average Analyst Price Target: $84.61 (-4.44%)
GILD Market Cap: $110.34B
Expected Ex-Dividend Date for GILD stock: Dec 14 2022
Expected Payment Date for GILD stock: Dec 29 2022
Expected Dividend & Yield for GILD stock: 3.24%
Recent Analyst Action: Elmar Kraus, analyst at DZ BANK AG, reiterates coverage on Gilead Sciences (GILD) stock in the Healthcare sector with a Hold rating and a price target of $ 90 (3 days ago).
TipRanks.com also reports that Gilead Sciences stock currently has 19 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $84.61 . The target pricing ranges from a high forecast of $105.00 down to a low forecast of $63.00. Gilead Sciences (GILD)’s last closing stock price was $88.54 which would put the average price target at -4.44% upside.Here are 3rd party ratings for GILD stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Buy, Top 22% (56 out of 249)
--------------------------------------------------------------------------
Merck & Company
Symbol: MRK
Recent MRK Stock Price: $108.97
Average Analyst Price Target: $110.27 (1.19%)
MRK Market Cap: $275.80B
Expected Ex-Dividend Date for MRK stock: Dec 14 2022
Expected Payment Date for MRK stock: Jan 09 2023
Expected Dividend & Yield for MRK stock: 2.54%
Recent Analyst Action: Geoff Meacham, analyst at Bank of America Securities, reiterates coverage on Merck & Company (MRK) stock in the Healthcare sector with a Hold rating and a price target of $ 110 (23 hours ago).
TipRanks.com also reports that Merck & Company stock currently has 16 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $110.27 . The target pricing ranges from a high forecast of $122.00 down to a low forecast of $100.00. Merck & Company (MRK)’s last closing stock price was $108.97 which would put the average price target at 1.19% upside.Here are 3rd party ratings for MRK stock:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Top 39% (97 out of 249)
--------------------------------------------------------------------------
Thermo Fisher
Symbol: TMO
Recent TMO Stock Price: $567.6
Average Analyst Price Target: $618.43 (8.96%)
TMO Market Cap: $219.72B
Expected Ex-Dividend Date for TMO stock: Dec 14 2022
Expected Payment Date for TMO stock: Jan 16 2023
Expected Dividend & Yield for TMO stock: 0.20%
Recent Analyst Action: Conor McNamara, analyst at RBC Capital, reiterates coverage on Thermo Fisher (TMO) stock in the Healthcare sector with a Buy rating and a price target of $ 661 (6 days ago).
TipRanks.com also reports that Thermo Fisher stock currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $618.43 . The target pricing ranges from a high forecast of $661.00 down to a low forecast of $565.00. Thermo Fisher (TMO)’s last closing stock price was $567.6 which would put the average price target at 8.96% upside.Here are 3rd party ratings for TMO stock:
- TipRanks.com: Strong Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 38% (94 out of 249)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
